<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101731727</journal-id>
<journal-id journal-id-type="pubmed-jr-id">47938</journal-id>
<journal-id journal-id-type="nlm-ta">Biochim Biophys Acta Mol Cell Biol Lipids</journal-id>
<journal-id journal-id-type="iso-abbrev">Biochim Biophys Acta Mol Cell Biol Lipids</journal-id>
<journal-title-group>
<journal-title>Biochimica et biophysica acta. Molecular and cell biology of lipids</journal-title>
</journal-title-group>
<issn pub-type="ppub">1388-1981</issn>
<issn pub-type="epub">1879-2618</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30408523</article-id>
<article-id pub-id-type="pmc">6432790</article-id>
<article-id pub-id-type="doi">10.1016/j.bbalip.2018.10.010</article-id>
<article-id pub-id-type="manuscript">NIHMS1511687</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>iPLA<sub>2</sub>β and its Role in Male Fertility, Neurological Disorders, Metabolic Disorders, and Inflammation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Turk</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>White</surname>
<given-names>Tayleur D.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nelson</surname>
<given-names>Alexander J.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Xiaoyong</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramanadham</surname>
<given-names>Sasanka</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Medicine, Washington University School of Medicine, St. Louis, MO</aff>
<aff id="A2"><label>2</label>Department of Cell, Developmental, and Integrative Biology</aff>
<aff id="A3"><label>3</label>Conprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL.</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Address Correspondence to: Sasanka Ramanadham, PhD, University of Alabama at Birmingham, 1825 University Blvd., Birmingham, AL 35294, 205-996-5973 (off); 205-996-5220 (Fax)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>5</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<volume>1864</volume>
<issue>6</issue>
<fpage>846</fpage>
<lpage>860</lpage>
<!--elocation-id from pubmed: 10.1016/j.bbalip.2018.10.010-->
<abstract id="ABS1">
<p id="P1">The Ca<sup>2+</sup>-independent phospholipases, designated as group VI iPLA<sub>2</sub>s, also referred to as PNPLAs due to their shared homology with patatin, include the β, γ, δ, ε, ζ, and η forms of the enzyme. The iPLA<sub>2</sub>s are ubiquitously expressed, share a consensus GXSXG catalytic motif, and exhibit organelle/cell-specific localization. Among the iPLA<sub>2</sub>s, iPLA<sub>2</sub>β has received wide attention as it is recognized to be involved in membrane remodeling, cell proliferation, cell death, and signal transduction. Ongoing studies implicate participation of iPLA<sub>2</sub>β in a variety of disease processes including cancer, cardiovascular abnormalities, glaucoma, and peridonditis. This review will focus on iPLA<sub>2</sub>β and its links to male fertility, neurological disorders, metabolic disorders, and inflammation.</p>
</abstract>
<kwd-group>
<kwd>iPLA2β-derived lipids</kwd>
<kwd>signaling</kwd>
<kwd>membrane remodeling</kwd>
<kwd>immune responses</kwd>
<kwd>diabetes</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>